SomaLogic, a Boulder, Colorado-based biomarker discovery and clinical diagnostics company, is expected to go public via a merger with a special purpose acquisition company (SPAC). We'll update this page as new information becomes available.
What we know about the SomaLogic IPO
SomaLogic has entered into an agreement to go public via a merger with SPAC CM Life Sciences II Inc. The SPAC is backed by activist investor Keith Meister.
SPACs, also known as a blank check company, are companies with no commercial operations that exist purely to raise capital through IPOs. No date has been announced yet.
CM Life Sciences originally went public in February 2021 and currently trades on the Nasdaq under the ticker symbol "CMIIU."
How to buy shares in SomaLogic when it goes public
Once SomaLogic goes public, you'll need a brokerage account to invest. Consider opening a brokerage account today so you're ready as soon as the stock hits the market.
Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
Open your brokerage account. Complete an application with your details.
Confirm your payment details. Fund your account.
Research the stock. Find the stock by name or ticker symbol – – and research it before deciding if it's a good investment for you.
Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.
Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
Our pick for active traders. We picked Interactive Brokers for this category because it offers advanced tools and low fees for active investors and pros. The simpler IBKR Lite platform is aimed at less-active investors, but all users older than 21 must meet a $20,000 liquid net worth requirement for a cash account.
How do similar companies perform?
It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. But evaluating the performance of companies like SomaLogic can be useful in determining how the market is performing and whether now is a good time to invest in this industry.
Select a company to learn more about what they do and how their stock performs, including market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield. While this list includes a selection of the most well-known and popular stocks, it doesn't include every stock available.
Company summary
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
FMC Corporation, an agricultural sciences company, provides crop protection, plant health, precision agriculture, and professional pest and turf management products. The company develop, markets, and sells crop protection chemicals that include insecticides, herbicides, and fungicides that are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and disease, as well as in non-agricultural markets for pest control. It also offers biologicals products, such as bionematicides under the Quartzo and Presence names. The company sells herbicides under the Authority, Boral, Centium, Command, and Gamit brands, as well as Isoflex active herbicide ingredients; Rynaxypyr and Cyazypyr active ingredients; and insecticides under the Talstar and Hero brands, as well as flutriafol-based fungicides. It sells its products through independent distributors and co-ops, and national and regional distributors, as well as sells directly to growers. The company operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. FMC Corporation was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
Compare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Sheri Bechtel is the share trading and investments editor at Finder. She is a seasoned journalist who has reported on bonds, stocks, engineering and other topics for more than 20 years. For 12 years, she was a markets reporter for Prospect News, spearheading their coverage of private investments in public equities, high-yield debt, structured products and municipal bonds. Before joining Finder, Sheri was editor-in-chief of Plastics Engineering from Wiley. She has a bachelor’s degree in English from Columbus State University and a side gig as a novelist.
How likely would you be to recommend finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
Advertiser Disclosure
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.